# Sprint 7 Checkpoint — Clinical Evidence & Predicate Analysis

**Timestamp:** 2026-02-07 23:15 MST
**Total Tests:** 1205 (exceeds target of 1,181)
**Sprint Status:** COMPLETE

---

## Summary

Sprint 7 establishes the Clinical Evidence Hierarchy and Predicate Device Analysis
infrastructure, completing the evidence strength and substantial equivalence
demonstration capabilities per GUI-0102 and SOR/98-282 s.32(4).

---

## Sprint 7A: Clinical Evidence Model (53 tests)

**File:** `src/core/clinical_evidence.py`

### Key Models
- `ClinicalEvidence`: Individual study with quality scoring
- `ClinicalEvidencePortfolio`: Device version evidence collection
- `ClinicalPackageAssessment`: Class-specific sufficiency evaluation

### Evidence Hierarchy Scoring (GUI-0102)
```python
EVIDENCE_HIERARCHY_SCORE = {
    "randomized_controlled_trial": 1.0,
    "prospective_cohort": 0.85,
    "retrospective_cohort": 0.70,
    "registry_data": 0.60,
    "case_control": 0.55,
    "case_series": 0.40,
    "case_report": 0.25,
    "expert_opinion": 0.15,
    "literature_review": 0.15,
}
```

### Class Thresholds
- Class I: 0.0 (no clinical evidence required)
- Class II: 0.40 (case series level)
- Class III: 0.60 (registry data or better)
- Class IV: 0.85 (prospective cohort or better)

---

## Sprint 7B: Predicate Device Analysis (38 tests)

**File:** `src/core/predicate_analysis.py`

### Key Models
- `PredicateDevice`: Predicate identification and comparison dimensions
- `PredicateComparisonMatrix`: Detailed 3-dimension assessment
- `SubstantialEquivalenceReport`: SE determination with rationale

### Comparison Dimensions (SOR/98-282 s.32(4))
1. **Intended Use** (35% weight): Purpose and indication equivalence
2. **Technological Characteristics** (35% weight): Materials, principles, design
3. **Performance** (30% weight): Safety and effectiveness data

### Equivalence Conclusions
- `substantially_equivalent`: All dimensions equivalent
- `substantially_equivalent_with_data`: Differences addressed with data
- `not_equivalent`: Significant unaddressed differences
- `requires_additional_analysis`: More information needed

---

## Sprint 7C: Clinical/Predicate Gap Rules (20 tests, 16 total rules)

**File:** `src/core/gap_engine.py` (updated)

### New Rules
| Rule ID | Name | Severity | Category |
|---------|------|----------|----------|
| GAP-014 | Insufficient clinical evidence strength | critical | evidence_strength |
| GAP-015 | No predicate device identified | major | completeness |
| GAP-016 | Technological differences unaddressed | critical | evidence_strength |

### Rule Details

**GAP-014:** Checks if clinical evidence portfolio score meets class threshold:
- Triggers when weighted_quality_score < CLASS_EVIDENCE_THRESHOLDS[device_class]
- References: GUI-0102, SOR-98-282-S32-4

**GAP-015:** Class II/III devices should have predicate comparisons:
- Triggers when no PredicateDevice records exist for device version
- References: SOR-98-282-S32-4, GUI-0098

**GAP-016:** Predicate differences must have documented mitigations:
- Triggers when technological_differences exist but technological_mitigations is empty
- References: SOR-98-282-S32-4

---

## Commits

```
98f0d03 Sprint 7C: Clinical/Predicate Gap Rules (1205 tests, 16 rules)
bf31f6f Sprint 7B: Predicate Device Analysis (1185 tests, SOR/98-282 s.32(4))
79f884a Sprint 7A: Clinical Evidence Model (1147 tests, GUI-0102 aligned)
```

---

## Test Coverage

| Module | Tests |
|--------|-------|
| test_clinical_evidence.py | 53 |
| test_predicate_analysis.py | 38 |
| test_gap_engine.py | 125 (including new GAP-014/15/16) |
| **Sprint 7 Total** | ~111 new tests |

---

## Exit Criteria Met

- [x] ClinicalEvidence model with hierarchy scoring
- [x] PredicateDevice model with comparison dimensions
- [x] GAP-014, GAP-015, GAP-016 rules integrated
- [x] 1,205 tests passing (target: 1,181)
- [x] Checkpoint created with MST timestamp

---

## Regulatory References Used

- **GUI-0102**: Guidance on Clinical Evidence for Medical Devices
- **SOR/98-282 s.32(4)**: Substantial equivalence demonstration
- **GUI-0098**: Premarket Guidance for Medical Devices
- **ISO 14971:2019**: Risk management for medical devices

---

## Next: Sprint 8 — Design Controls

Sprint 8 implements ISO 13485 Section 7.3 design control traceability:
- 8A: Design Control Entities (DesignInput, DesignOutput, DesignVerification, DesignValidation)
- 8B: Design Traceability Links (input→output→verification→validation chain)
- 8C: Design History File generation

---

*Platform Version: Sprint 7 Complete*
*Health Canada Medical Device Regulatory Execution Platform*
